Cell transplantation success for myocardial infarction (MI) treatment is often hindered by low engraftment due to washout effects during myocardial contraction. A clinically viable biomaterial that enhances cell retention could optimize intramyocardial cell delivery. In this study, we developed a therapeutic cell delivery method for MI treatment utilizing a photocrosslinkable gelatin methacryloyl (GelMA) hydrogel. Human vascular progenitor cells, capable of forming functional vasculatures upon transplantation, were combined with an in‐situ photopolymerization approach and injected into the infarcted zones of mouse hearts. Our strategy substantially improved acute cell retention and promoted long‐term post‐MI cardiac healing, including stabilized cardiac functions, preserved viable myocardium, and reduced cardiac fibrosis. Additionally, engrafted vascular cells polarized recruited bone marrow‐derived neutrophils toward a non‐inflammatory phenotype via TGFβ signaling, fostering a pro‐regenerative microenvironment. Neutrophil depletion negated the therapeutic benefits generated by cell delivery in ischemic hearts, highlighting the essential role of non‐inflammatory, pro‐regenerative neutrophils in cardiac remodeling. In conclusion, our GelMA hydrogel‐based intramyocardial vascular cell delivery approach holds promise for enhancing the treatment of acute myocardial infarction.This article is protected by copyright. All rights reserved